Rockwell Medical Inc
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -15.8% | -0.2% | -10.5% | 5.6% | 15.1% | 3.5% | -18.4% | 11.5% | -8.2% | 12.5% | -1.0% | 11.7% | 4.2% | |
| 2.4% | 2.5% | 2.4% | 2.1% | 1.9% | 2.2% | 2.8% | 3.5% | 3.4% | 3.0% | 2.9% | 2.8% | 3.0% | |
| 0.9% | 1.0% | 1.1% | 1.3% | 1.1% | 1.5% | 2.4% | 2.4% | 3.3% | 2.5% | 2.8% | 2.3% | 2.7% | |
| -17.4% | -2.3% | -9.6% | -0.7% | 3.0% | 0.0% | -19.8% | 11.1% | -6.9% | 7.8% | -1.2% | 11.0% | 3.0% | |
| 0.1% | 0.2% | 0.6% | 1.1% | 0.7% | 1.6% | 0.3% | 1.0% | 1.4% | 0.5% | 2.5% | 3.5% | 2.0% | |
| -43.3% | 9.1% | -0.6% | 6.6% | -21.6% | -1.3% | 0.0% | -0.6% | -27.1% | -22.5% | -0.7% | -2.7% | -13.0% | |
| – | – | – | – | -1.2% | -1.4% | -1.8% | -1.3% | -2.0% | -1.7% | -1.8% | -1.0% | -1.6% | |
| 54.0% | -3.4% | 0.8% | 8.0% | 8.2% | 11.3% | -4.1% | -4.0% | 42.3% | -5.8% | -4.7% | -3.8% | 6.0% | |
| -5.0% | 5.5% | -10.3% | 20.2% | 1.7% | 13.5% | -22.6% | 6.8% | 7.1% | -15.8% | -6.4% | 5.1% | -2.8% | |
| -15.9% | -0.4% | -11.1% | 4.5% | 14.4% | 1.9% | -18.8% | 10.5% | -9.6% | 12.0% | -3.4% | 8.2% | 2.2% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.